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toward TNFα-mediated cytotoxicity. This was related to an 
adaptive primary protective response of Nrf2, since loss of 
Nrf2 enhanced this cytotoxic synergy with TNFα, while 
KEAP1 downregulation was cytoprotective. These data indi-
cate that both Nrf2 and NF-κB signaling may be pivotal in 
the regulation of DILI. We propose that the NF-κB-inhibiting 
effects that coincide with a strong Nrf2 stress response likely 
sensitize liver cells to pro-apoptotic signaling cascades 
induced by intrinsic cytotoxic pro-inflammatory cytokines.
Keywords Drug-induced liver injury · Live-cell 
imaging · Nrf2 activation · Oxidative stress · NF-κB 
signaling
Abbreviations
BHA  Butylated hydroxyanisole
DILI  Drug-induced liver injury
PHH  Primary human hepatocytes
siRNA  Small interfering RNA
















Abstract Drug-induced liver injury (DILI) is an impor-
tant problem both in the clinic and in the development of 
new safer medicines. Two pivotal adaptation and survival 
responses to adverse drug reactions are oxidative stress and 
cytokine signaling based on the activation of the transcrip-
tion factors Nrf2 and NF-κB, respectively. Here, we system-
atically investigated Nrf2 and NF-κB signaling upon DILI-
related drug exposure. Transcriptomics analyses of 90 DILI 
compounds in primary human hepatocytes revealed that a 
strong Nrf2 activation is associated with a suppression of 
endogenous NF-κB activity. These responses were translated 
into quantitative high-content live-cell imaging of induction 
of a selective Nrf2 target, GFP-tagged Srxn1, and the altered 
nuclear translocation dynamics of a subunit of NF-κB, GFP-
tagged p65, upon TNFR signaling induced by TNFα using 
HepG2 cells. Strong activation of GFP-Srxn1 expression 
by DILI compounds typically correlated with suppression 
of NF-κB nuclear translocation, yet reversely, activation 
of NF-κB by TNFα did not affect the Nrf2 response. DILI 
compounds that provided strong Nrf2 activation, includ-
ing diclofenac, carbamazepine and ketoconazole, sensitized 
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Drug safety issues that lead to drug-induced liver injury 
(DILI) are the major reason for drug-related hospitaliza-
tions and drug withdrawals. Often with no overt changes in 
hepatocellular toxicity parameters (e.g., rise in alanine or 
aspartate aminotransferase (ALT/AST) levels or increased 
total bilirubin) found in preclinical settings, drugs are 
(unknowingly) safely marketed until more than 1 in 10,000 
drug users demonstrate signs of liver failure (Kaplowitz 
2005). Novel, predictive systems for DILI based on mecha-
nistic understanding will be essential to pave the way for-
ward for improved drug safety assessment.
The common notion around DILI is that drugs affect the 
intracellular biochemistry of liver cells, elicited by either 
the parent drug, its metabolites, or the metabolic shift 
the drug conveys upon uptake (Han et al. 2013; Kaplow-
itz 2005). Although often idiosyncratic, there is a need to 
understand the key events that are critical mechanistic 
determinants of human DILI. Perturbations of immune-
mediated signaling seem an important event in DILI (Steu-
erwald et al. 2013). In particular, TNFα-mediated signaling 
seems an important contributor to sensitize liver cells to 
drug-induced hepatocyte toxicity both in vitro (Cosgrove 
et al. 2009) and in vivo (Shaw et al. 2007). TNFα mediates 
intracellular signaling through activation of NF-κB tran-
scription factor (Mercurio et al. 1997). NF-κB transiently 
translocates to the nucleus to activate downstream (cyto-
protective) target genes including chemokines, inhibitor of 
apoptosis protein family members (IAPs) and anti-apop-
totic Bcl2 family members (Liu et al. 1996). We demon-
strated that for diclofenac (DCF), the synergy with TNFα 
to kill hepatocytes is directly related to inhibition of NF-κB 
nuclear translocation and activation and that inhibition of 
NF-κB signaling sensitizes toward cytotoxicity caused by 
DCF (Fredriksson et al. 2011).
Bioactivation of drugs contributes to the formation 
of reactive metabolites which is shown to be a risk fac-
tor in DILI (Leung et al. 2012). These reactive metabo-
lites typically provoke a cellular oxidative stress environ-
ment, thereby initiating the stabilization and activation of 
the transcription factor Nrf2 (Li et al. 2005). Subsequent 
downstream target gene activation by Nrf2 contributes to 
adaptation and protection of cells against oxidative stress. 
Likewise, Nrf2 deletion in the liver severely increases the 
sensitivity toward drug-induced liver failure (Liu et al. 
2010, 2013). In some studies, it has been shown that Nrf2 
activation can act to suppress NF-κB-based immune signal-
ing responses (Chen et al. 2006), which is interesting as this 
would suggest that Nrf2 could be involved in NF-κB sup-
pression in certain situations including DILI. So far, there 
is no systematic evaluation on the relationship between 
Nrf2 and NF-κB activation in DILI.
Here, we investigated whether drugs with known risk of 
DILI invoke specific cellular stress and defense pathways 
(NF-κB and Nrf2) and if these can aid in predicting the 
degree of drug toxicity and whether associations between 
these pathways exist. We investigated the transcriptional 
response to 90 DILI-associated drugs as well as several 
cytokines/growth factors in primary human hepatocytes 
(PHH) at multiple concentrations and time points, based 
on publicly available data (Uehara et al. 2010). To translate 
these findings to high-throughput approaches, we established 
novel GFP-based reporter cell lines amenable for high-
content high-throughput live-cell imaging to quantitatively 
assess Nrf2 and NF-κB activation on a cell-to-cell basis. 
Our combined data indicate that the degree of oxidative 
stress in liver cells negatively correlates with NF-κB activ-
ity and that the inability to adequately respond to inflamma-
tory responses upon drug exposure predisposes liver cells 
toward cell death. We propose that our integration of live-cell 
high-content imaging models to determine Nrf2 and NF-κB 
activation as well as cytotoxicity is likely to contribute to 
improving the discrimination of novel drug entities that are 
intrinsically at risk of DILI.
Materials and methods
Reagents
All drugs were acquired from Sigma-Aldrich and freshly 
dissolved in DMSO, except for menadione (MEN) and 
naproxen (NPX) (in PBS). Human TNFα was purchased 
from R&D systems and stored as 10 μg/mL in 0.1 % BSA 
in PBS aliquots.
Cell culture
Human hepatoma HepG2 cells were acquired from ATCC 
(clone HB8065) and maintained and exposed to drugs in 
DMEM high glucose supplemented with 10 % (v/v) FBS, 
25 U/mL penicillin and 25 μg/mL streptomycin. The cells 
were used between passage 5 and 20. For live-cell imag-
ing, the cells were seeded in Greiner black μ-clear 96-well 
plates, at 20,000 cells per well.
Gene expression analysis
CEL files were downloaded from the Open TG-GATEs 
database for all DILI-related compounds (see Sup-
plementary Table 1): “Toxicogenomics Project and 
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Toxicogenomics Informatics Project under CC Attribution-
Share Alike 2.1 Japan” http://dbarchive.biosciencedbc.
jp/en/open-tggates/desc.html. Probe annotation was per-
formed using the hthgu133pluspmhsentrezg.db package 
version 17.1.0, and probe mapping was performed with 
hthgu133pluspmhsentrezgcdf downloaded from NuGO 
(http://nmg-r.bioinformatics.nl/NuGO_R.html). Probe-
wise background correction (robust multi-array average 
expression measure), between-array normalization within 
each treatment group (quantile normalization) and probe 
set summaries (median polish algorithm) were calculated 
with the rma function of the Affy package (Affy package, 
version 1.38.1) (Irizarry et al. 2003). The normalized data 
were statistically analyzed for differential gene expression 
using a linear model with coefficients for each experimen-
tal group within a treatment group (Wolfinger et al. 2001).
A contrast analysis was applied to compare each expo-
sure with the corresponding vehicle control. For hypoth-
esis testing, the empirical Bayes statistics for differential 
expression was used followed by an implementation of 
the multiple testing correction of Benjamini and Hochberg 
(1990) using the LIMMA package (Smyth et al. 2005).
Cluster analysis of oxidative stress 
and inflammation‑regulated gene sets
A gene set for oxidative stress and a gene set for inflam-
matory signaling were generated using several databases 
(see Supplementary Fig 1). From Ingenuity Pathway Analy-
sis (version 18841524), the genes present in the following 
pathways were extracted: NRF2-mediated oxidative stress 
response, death receptor signaling, NF-κB signaling, TNFR1 
signaling, TNFR2 signaling and Toll-like receptor signaling. 
From the Gene Ontology Project (Ashburner et al. 2000), 
genes associated with the following terms were obtained 
using AmiGO 2 version 2.2.0 (Carbon et al. 2009): response 
to oxidative stress (GO:0006979) for oxidative stress and 
regulation of inflammatory response (GO:0050727) for 
inflammatory signaling. Both queries were performed with 
filters evidence-type closure set to “experimental evidence” 
and taxon closure label set to “Homo sapiens.”
From the Molecular Signatures Database (MSigDB) 
(Liberzon et al. 2011), for oxidative stress the following 
gene sets from BioCarta were used: BIOCARTA NRF2 
PATHWAY and for inflammatory signaling BIOCARTA 
NFKB PATHWAY, BIOCARTA DEATH PATHWAY, BIO-
CARTA TNFR1 PATHWAY, BIOCARTA TNFR2 PATH-
WAY and BIOCARTA TOLL PATHWAY.
From Kyoto Encyclopedia of Genes and Genomes (KEGG 
Release 71.0, July 1, 2014): (Kanehisa et al. 2014) the path-
ways NF-κ B signaling pathway, TNF signaling pathway and 
Toll-like receptor signaling pathway were used for inflamma-
tory signaling. No entry for Nrf2 or oxidative stress was found. 
From Reactome (version 48) (Croft et al. 2014) the path-
ways innate immune system and detoxification of reactive oxy-
gen species (ROS) were used for inflammatory signaling and 
oxidative stress signaling, respectively. From “TRANSFAC® 
(www.biobase-international.com/transcription-factor-binding-
sites) from BIOBASE Corporation” (Qian et al. 2006), the 
genes bound by factor NFE2L2 and RELA were used for oxi-
dative stress and inflammatory signaling, respectively.
From all databases, a total of 490 and 175 unique genes 
were obtained for inflammatory and oxidative stress signaling, 
respectively. As a next step to determine whether the selected 
genes are actively transcribed in PHH of the TG-GATEs data-
set, another selection step was performed using the oxidative 
stress model compounds: di-ethyl maleate (DEM) and butyl-
ated hydroxyanisole (BHA), and inflammatory model treat-
ments: TNFα, LPS and interleukin-1β; both for the high-dose 
8- and 24-h data. The oxidative stress gene set was filtered 
based on a multiple-testing-corrected p value of 0.05, minimum 
average expression of 5 (log2) and a minimum absolute log2-
fold change of 1.5 within the oxidative stress model compound 
subset resulting in 55 genes. The inflammatory signaling gene 
set was filtered based on a multiple-testing-corrected p value of 
0.05, minimum average expression of 5 (log2) and a minimum 
absolute log2-fold change of 2 within the inflammatory signal-
ing model treatment subset resulting in 82 genes. The log2-fold 
change values for all DILI treatments and controls were gath-
ered followed by Manhattan distance measure and ward clus-
tering using the NMF package (version 0.20.5) (Gaujoux and 
Seoighe 2010). Different log2-fold change threshold values 
were used to obtain more similar gene set sizes.
The DILI score annotation was adapted from the manual 
literature survey performed by Astrazeneca (Garside et al. 
2014). The DILI concern and SeverityScore were largely 
based on a text mining study of FDA labels (Chen et al. 
2011).
Ingenuity Pathway Analysis
Differentially expressed genes for all DILI compounds in 
the TG-GATEs dataset were selected based on a minimal 
log2-fold change of 1.3 (fold change of 2.5 × with respect 
to matched control), a maximum multiple-testing-corrected 
p value of 0.05 and a minimum average log2 expression of 
7 within the treatment groups (Supplementary Fig 1). Clas-
sification of the selected genes according to their biologi-
cal and toxicological functions was generated through the 
use of QIAGEN’s Ingenuity Pathway Analysis (IPA®, QIA-
GEN Redwood City, www.qiagen.com/ingenuity), which 
finds associated canonical pathways based on the selected 
gene sets. p values are calculated using right-tailed Fisher 
exact test and represented as −log10 (p values). The p val-
ues were extracted for the “Nrf2-mediated oxidative stress 
response” pathway representing oxidative stress, and as 
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representation for “inflammatory signaling,” the average 
of the p values of pathways “Toll-like receptor signaling,” 
“death receptor signaling,” “TNFR1 signaling,” “TNFR2 
signaling” and “NF-κB signaling” was calculated. For each 
treatment, the average magnitude of the log2-fold change 
values of the genes responsible for the significance of the 
oxidative stress and inflammatory pathways was calculated 
and displayed as an arrow vector above the −log10 p value 
bars of the bar graph. The number of genes responsible for 
the significance of the individual pathways is color-coded 
from blue (low number of genes) to pink (high number of 
genes).
Generation of GFP‑tagged cell lines
HepG2 cells stably expressing human GFP-p65 as 
described in (Fredriksson et al. 2011). Mouse sulfiredoxin 
(Srxn1) was tagged with GFP at the C-terminus using BAC 
recombineering (Hendriks et al. 2012) and stably intro-
duced into HepG2 cells by transfection and 500 μg/mL 
G-418 selection.
RNA interference
siRNAs against human NFE2L2 (Nrf2) and KEAP1 were 
acquired from Dharmacon (ThermoFisher Scientific) as 
siGENOME SMARTpool reagents, as well as in the form 
of four individual siRNAs. HepG2 cells were transiently 
transfected with the siRNAs (50nM) using INTERFERin 
(Polyplus) as described previously (Fredriksson et al. 
2011).
Western blotting
Samples were collected by direct cell lysis (including pel-
leted apoptotic cells) in 1 × sample buffer supplemented 
with 5 % v/v β-mercaptoethanol and heat-denatured at 
95 °C for 10 min. The separated proteins were blotted onto 
PVDF membranes before antibody incubation in 1 % BSA 
in TBS–Tween 20. The following antibodies were used: 
mouse-anti-GFP (Roche); rabbit-anti-IκBα (Cell Signal-
ing); rabbit-anti-Nrf2 (H300, Santa-Cruz); mouse-anti-
Cleaved Caspase-8 (Cell Signaling); rabbit-anti-PARP 
(Cell Signaling); mouse-anti-Tubulin (Sigma); mouse-anti-
actin (Santa-Cruz).
Microscopy
Real-time cell death induction was determined by moni-
toring the accumulation of Annexin-V-Alexa633-labeled 
cells over a 24-h time period (Puigvert et al. 2010). For 
this, transmission and Alexa633 images of the same area 
with cells were taken automatically every 30 min using a 
BD Pathway™ 855 bioimager with CCD camera and a 10x 
objective with an image resolution of 608 × 456 (binning 
2).
Accumulation of Srxn1-GFP or nuclear oscillation of 
GFP-p65 was monitored using a Nikon Eclipse Ti confo-
cal microscope (lasers: 488 and 408 nm), equipped with 
an automated stage, Nikon 20x Dry PlanApo VC NA 0.75 
objective and perfect focus system. Images were acquired 
at 512 × 512 pixels. Prior to imaging at >20× magnifica-
tion, HepG2 cells were loaded for 45 min with 100 ng/mL 
Hoechst33342 to visualize the nuclei, upon which the Hoe-
chst-containing medium was washed away to avoid Hoe-
chst phototoxicity (Purschke et al. 2010). Srxn1-GFP cells 
were imaged every 30 min across a 24-h time span, and 
GFP-p65 cells every 6 min for 6 h.
Image quantification
To quantify the total pixel area occupied by cells or the 
number of cells per field imaged, transmission images and 
Hoechst images, respectively, were analyzed using Image-
Pro 7.0 (Media Cybernetics). The accumulation of dead 
cells or the appearance of Srxn1-GFP-positive cells was 
quantified as the total number of pixels above background. 
The Annexin-V-positive pixel total was normalized for the 
total cell area. The number of adjacent fluorescent Srxn1-
GFP pixels above background (with a minimum size of 
45 pixels, which is about one-fourth of average cell size) 
was multiplied by the average density of those pixels as a 
Fig. 1  Gene expression analysis of 24-h highest concentration primary 
human hepatocyte subset of the TG-GATEs dataset. a Differentially 
expressed genes were analyzed with Ingenuity Pathway Analysis as 
described in detail in the “Materials and methods” section. In the top 
panel, the −log10 p values for the corresponding pathways are displayed 
for the Nrf2-mediated oxidative stress response. The top panel dis-
plays the mean of the p values for the inflammatory-related pathways. 
Compounds are ordered according to highest significance of the Nrf2-
mediated oxidative stress response. The compound labels in red are the 
compounds chosen in this study. The color of the bars corresponds to 
DILI severity type or to the oxidative stress/inflammatory model com-
pounds (model compound type). The length of the arrows corresponds 
to the mean fold change of the genes which are responsible for the sig-
nificance of the corresponding pathways. The direction of the arrow 
corresponds to either mean up- or downregulation of these genes. The 
color of the arrows corresponds to the number of these genes rang-
ing from 10 to 60 genes. b Unsupervised hierarchical clustering of all 
DILI compounds and a selected gene set as described in detail in the 
“Materials and methods” section. Blue corresponds to downregulated 
genes, and orange, to upregulated genes; the brightness corresponds to 
the magnitude of the fold changes. The top color-coded bar corresponds 
to the DILI concern or model compound type. The second top color-
coded bar corresponds to the severity class or model compound type. 
The left color-coded bar corresponds to the gene type—either inflamma-
tory genes, oxidative genes or both. Important clusters on gene level are 
represented from A′ to H′, and important compound-level clusters with 
A–E for easy reference from the text. Compounds used in this study are 
color-coded in red (color figure online)
◂
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measure for the GFP signal intensity increase and normal-
ized for the amount of nuclei.
To quantify the nuclear translocation of GFP-p65, 
nuclei (Hoechst) masks are segmented and tracked in 
ImageJ to define the GFP-p65 nuclear intensity, followed 
by cytoplasm segmentation. The normalized nuclear/cyto-
plasmic intensity ratio for each cell is recorded and fur-
ther analyzed for different oscillation features, also using 
ImageJ, including the number of translocations, time 
period of each individual peak, intensity of the peaks, 
delay between peaks, and nuclear entry and exit rates (Di 
et al. 2012).
Statistics
All experiments are performed at least in triplicate. Error 
bars indicate standard error. Statistical comparisons were 
made using a one-way ANOVA. The following p values 
were considered significant: p < 0.05 (*); p < 0.01 (**); 
p < 0.001 (***).
Results
Enhanced Nrf2 activation is associated 
with suppression of endogenous NF‑κB activity in PHH
The Japanese Toxicogenomics Project has generated the 
Open TG-GATEs data repository of gene expression pro-

















































































































































































































































































































































































































































































































DILI Concern: inflammation less−DILI−concern most−DILI−concern oxidative stress
Fig. 2  Fold changes of example genes from the two prominent clus-
ters from the unsupervised hierarchical cluster analysis. Oxidative 
stress genes HMOX, SRXN1, GCLM (blue) from cluster B′ from 
Fig. 1b and inflammatory genes CXCL1, CCL2, BCL2A1 (purple) 
from clusters F′ and G′. Color codes are as in Fig. 1 (color figure 
online)
Fig. 3  Srxn1-GFP BAC HepG2 reporter cell line is dependent 
on Nrf2/KEAP1 signaling. a Cell injury assay using Annexin-V-
Alexa-633 staining after 24-h exposure to our compound set. b West-
ern blot of Nrf2 expression in HepG2 cells exposed for 8 or 16 h 
to MEN, di-ethyl maleate (DEM), diclofenac (DCF) or KTZ. Den-
sity quantification is relative to actin levels, normalized to DMSO. 
c Western blot of GFP expression in HepG2 Srxn1-GFP cells as in 
b. Density quantification below is relative to tubulin levels. d Stills 
of time-lapse imaging of HepG2 Srxn1-GFP cells exposed to Nrf2 
inducers. e Quantification of the Srxn1-GFP reporter response kinet-
ics. f siRNA-mediated knockdown of Nrf2 (+siNrf2) or KEAP1 
(siKEAP1) or mock treatment (−) in HepG2 Srxn1-GFP cells 
exposed to DMSO, MEN, DEM, DCF or KTZ for 24 h
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many are DILI-related, at 1–3 different concentrations 
and 1–3 time points (2, 8 and 24 h), including a few pro-
inflammatory cytokines, TNFα, IL1β and LPS (Uehara 
et al. 2010). We focused on the NF-κB and Nrf2 signaling-
related gene sets extracted from several key databases as 
described in detail in the “Materials and methods” section. 
Ingenuity Pathway Analysis (IPA) for oxidative stress and 
inflammatory signaling was performed for all DILI com-
pounds in the dataset. Typically, a significant modulation of 
these pathways was observed. A major modulation of the 
“Nrf2-mediated oxidative stress response” overall related 
to upregulation of genes linked to this pathway. Interest-
ingly, DILI compounds that showed a strong oxidative 
stress response also showed a modulation of “inflamma-
tory signaling” related to NF-κB activity (26 compounds, 
p < 0.05) although this was typically associated with down-
regulation of genes (Fig. 1a). This effect was strongest after 
24-h treatment, although a similar association was already 
observed at 8-h treatment (Supplementary Fig. 2A).
The above observation indicated an opposite direction of 
Nrf2-mediated signaling versus NF-κB-related inflamma-
tory signaling by DILI compounds in PHH. Indeed, Nrf2 
can negatively affect NF-κB activity (Liu et al. 2008; Yu 
et al. 2011). Therefore, we next performed a more detailed 
hierarchical clustering analysis of the altered gene expres-
sion induced by all DILI compounds associated with both 
signaling pathways. As a first step, based on different 
annotation databases, we systematically selected a set of 
Nrf2 signaling-related genes as well as a set of inflamma-
tory signaling-related genes. To determine which genes are 
responsive to oxidative stress and inflammatory stimuli in 
PHH, we included a stringent filtering procedure based on 
the exposures of PHH in the TG-GATEs data to DEM and 
BHA for Nrf2 signaling, and TNFα, IL-1β and LPS for 
inflammatory signaling. We then extracted the differential 
expression levels for all DILI compounds for the selected 
55 and 82 genes related to Nrf2 signaling and inflamma-
tory signaling, respectively. Using an unsupervised hier-
archical clustering for all genes and DILI compounds at 
24 h, we could clearly distinguish Nrf2 clusters (A′, B′, C′ 
and E′) and NF-κB gene clusters (D′, F′ and G′) (Fig. 1b). 
Moreover, cytokines and LPS (cluster A) clearly induced a 
different response compared to all DILI compounds (clus-
ters B–E). DILI compound cluster C gave the strongest 
overall response at the level of both Nrf2 target gene acti-
vation and inflammation signaling target gene downregula-
tion; this cluster was slightly enriched in compounds that 
demonstrate “fatal hepatotoxicity”. These effects were not 
as prominent at 8-h treatment conditions (Supplementary 
Fig. 2B).
Within the hierarchical cluster analysis, two strong 
gene clusters were prominent in their response to DILI 
compounds: a first cluster (cluster B′) with Nrf2 target 
genes that were mostly upregulated by DILI compounds 
but hardly affected by cytokines, including Maff, Srxn1, 
Txnrd1, GCLM, SQSTM1, G6PD, FOS, MMP1 and 
HMOX1, mostly prototypical Nrf2 target genes (see Fig. 2 
for examples), and a second cluster (clusters F′ and G′) 
with inflammatory genes that were strongly upregulated by 
the cytokines and LPS, but were strongly downregulated 
by the same DILI compounds that caused upregulation of 
Nrf2 targets, which included CXCL1, CCL2, BCL2A1, 
CXCL11, CXCL2 (see Fig. 2 for examples). To deter-
mine the correlation with the DILI severity, we performed 
a similar cluster analysis for only severe DILI compounds 
and non-severe DILI compounds based on the FDA drug 
labeling classification (Chen et al. 2011) (Supplementary 
Figs. 3 and 4). Severe DILI compounds mostly mimicked 
the overall DILI hierarchical cluster analysis showing the 
strongest inverse relationship between Nrf2 activity and 
NF-κB suppression and included DCF, sulindac, ketocona-
zole (KTZ) and acetaminophen (APAP).
Altogether, these findings indicate a strong correlation 
between the ability of DILI compounds to induce an adap-
tive Nrf2 response and the suppression of NF-κB activity.
A BAC‑Srxn1‑GFP HepG2 cell line reports 
xenobiotic‑mediated Nrf2 activation
The most prominent differences between NF-κB and 
Nrf2 responses in the PHH dataset were observed at 
high concentrations and at 24 h of drug exposure. Like 
all signaling events, the transcriptional activities of Nrf2 
and NF-κB are dynamic in nature and may show differ-
ential activity over time. Therefore, we sought to moni-
tor the activity of these two transcription factors in liv-
ing cells using GFP-tagging technology allowing their 
dynamic analysis. As PHH dedifferentiate within 24 h 
in vitro when grown in 2D cultures (Boess et al. 2003) 
and are not amenable for stable expression of GFP 
reporter constructs, we chose the liver model cell line 
HepG2 to generate stable fluorescent reporters for both 
NF-κB and Nrf2 signaling. As a first step, to enable reli-
able quantitative measurements of the dynamic effect 
of drug exposure on Nrf2 activity using live-cell imag-
ing, we generated a HepG2 reporter cell line based on 
bacterial artificial chromosome (BAC) recombineering 
(Poser et al. 2008) of the Nrf2 target gene sulfiredoxin 
(Srxn1) (Hendriks et al. 2012), which was part of the 
predictive DILI cluster. We tagged the Srxn1 gene with 
GFP at its C-terminus and established a stably express-
ing HepG2 Srxn1-GFP cell line under control of its own 
entire promoter region. To monitor for its functionality 
as an Nrf2 reporter, we exposed the HepG2 cells to MEN 
(20 μM) and DEM (100 μM) as proto-typical model acti-
vators of Nrf2, as well as DCF and KTZ, of which the 
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Fig. 4  Drug exposure induces dynamically divergent Nrf2 responses. 
a Stills of confocal live-cell imaging in HepG2 Srxn1-GFP cells upon 
drug exposure (shown are 4, 14 and 24 h). b Quantification of the 
Srxn1-GFP signal appearing upon exposure to increasing drug doses 
(averages shown of four independent replicates). c Western blots for 
Nrf2 and GFP expression after 24-h drug exposure in HepG2 Srxn1-
GFP cells, either with or without co-exposure to 10 ng/mL TNFα. d 
Quantification of the Nrf2 and Srxn1-GFP protein levels, 24 h after 
drug ±TNFα exposure (averages of three replicates)
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PHH data revealed their capacity to strongly activate an 
Nrf2 response. DEM, MEN, DCF and KTZ all stabilized 
Nrf2 levels in our cells (Fig. 3b, c). Live-cell imaging 
by confocal microscopy followed by automated image 
quantification showed that the Srxn1-GFP reporter is 
activated with different kinetics by different compounds 
with MEN and DEM being fast inducers, likely related 
to their direct mode-of-action, and DCF and KTZ show-
ing a delayed response, possibly related to bioactivation 
(Fig. 3b–e); this effect was directly related to the expres-
sion of the GFP-Srxn1 fusion product. Finally, to con-
firm that our Srxn1-GFP reporter is under direct control 
of the KEAP1/Nrf2 pathway, we transiently transfected 
the HepG2 Srxn1-GFP cells with siRNA oligos target-
ing Nrf2 or KEAP1. siRNA targeting Nrf2 prevented 
the stabilization of Nrf2 and consequently inhibited the 
Srxn1-GFP induction for all compounds. In contrast, as 
expected, KEAP1 knockdown itself stimulated Srxn1-
GFP expression (Fig. 3f). These data show that the 
Srxn1-GFP signal intensity depends on the functional 
KEAP1/Nrf2 pathway.
Drug‑induced cell death of human HepG2 cells
Next, we selected a set of DILI compounds for further 
characterization. Since the opposite regulation of Nrf2 
versus NF-κB by DILI compounds was largely seen for 
severe DILI compounds that often require bioactivation, 
we selected a small panel of compounds that was con-
tained within the TG-GATEs dataset [APAP, carbamaz-
epine (CBZ), clozapine (CLZ), DCF, KTZ, nitrofurantoin 
(NTF) and nefazadone (NFZ)] as well as some DILI com-
pounds that do not require bioactivation and do not acti-
vate the Nrf2 pathway much in PHH [amiodarone (AMI), 
NPX and simvastatin (SN)]; we further complemented 
our compound set with a few additional drugs that fit in 
these categories but were not included in the TG-GATEs 
[ofloxacin (OFX), isoniazid (INH), methotrexate (MTX), 
3′-hydroxyacetanilide (AMAP) and troglitazone (TGZ)] 
(Supplementary Table 2). We first tested whether these 
compounds induced sufficient cell injury that resulted in 
cell death at similar concentrations as used for the PHH 
dataset (Fig. 3a). Based on automated live-cell imaging 
of Annexin-V-positive cells, we identified concentration-
dependent HepG2 cell death for AMI, APAP, AMAP, CBZ, 
CLZ, DCF, KTZ, NFZ, NTF and SN. Little cell death was 
observed for INH, MTX, NPX, OFX and TGZ. For fur-
ther experiments, we continued with a mildly cytotoxic 
concentration (<10 % apoptosis onset) for each compound 
(indicated in Supplementary Fig. 5) to establish the effect 
on Nrf2 activation, NF-κB signaling and the cytotoxic 
interaction between DILI compounds and the pro-inflam-
matory cytokine TNFα.
DILI compounds activate the Nrf2 stress response 
independent of TNFR activation
The PHH dataset predicted that APAP, CBZ, CLZ, DCF, 
KTZ and NTF potently activate the Nrf2 response; that 
INH, NFZ and NPX mildly induce Nrf2; and that AMI 
and SN weakly activate it (Supplementary Fig. 6). 
Using live-cell imaging, we tested whether these same 
drugs activated the Srxn1-GFP response in HepG2 cells 
(Fig. 4a, b). We observed that APAP induced the oxida-
tive stress reporter as soon as 4 h after compound expo-
sure, which is remarkable considering the low CYP2E1 
levels in HepG2 cells; however, this does indicate that the 
HepG2 is sensitive to oxidative stress adaptation sign-
aling. Possibly, APAP induces oxidative stress through 
other means than CYP2E1-mediated bioactivation, pos-
sibly involving direct modulation of the mitochondrial 
respiratory chain. NTF, DCF, KTZ, CLZ, CBZ and NFZ 
strongly induced the Srxn1-GFP reporter as early as 8 h 
after compound exposure. AMI, MTX and NPX showed 
weak Srxn1-GFP induction with delayed kinetics, around 
16 h after compound exposure. INH, OFX, SN and TGZ 
did not lead to oxidative stress induction within the 24-h 
imaging period in our cell system. These findings indi-
cate that the PHH results on the Nrf2 pathway activation 
correlate well with the HepG2 Srxn1-GFP reporter cell 
observations.
TNFα promotes NF-κB target gene activation through 
binding to TNFRSF1A. TNFα binding to its receptor has 
been suggested to promote Nrf2 activation (Rushworth 
et al. 2011), while the PHH dataset predicted no effect 
of TNFα on Nrf2 responses. To confirm this, we tested 
whether drug exposure in combination with 10 ng/mL 
TNFα influenced the drug-induced Nrf2 response (Fig. 4c, 
d). We observed neither a significant rise nor a decrease in 
Nrf2 stabilization or Srxn1-GFP expression at 24 h when 
the HepG2 Srxn1-GFP cells were exposed to TNFα alone 
or in combination with an 8-h drug pre-exposure. This sug-
gests that TNFα-mediated NF-κB signaling does not influ-
ence Nrf2 target gene activation caused by deleterious DILI 
compounds.
Fig. 5  DILI compounds affect the TNFα-mediated nuclear transloca-
tion response of NF-κB. a Time-lapse images of one cell that illus-
trates NF-κB oscillation upon 10 ng/mL TNFα stimulation after an 
8-h drug pre-incubation period. Arrowheads point at the local nuclear 
translocation maxima (“peaks”). Quantified average of the GFP-p65 
nuclear/cytoplasmic intensity ratio (average of three experiments, 
totaling 800–1200 cells), normalized between 0 and 1 to focus on 
the appearance of the nuclear translocation maxima. b Analysis of 
the NF-κB response: time between peaks 1 and 2. c Analysis of the 
NF-κB response: assessment of the number of peaks. d Distribution 
of the TNFα-stimulated, drug pre-exposed cell population, classified 
for showing 0–5 peaks within the 6-h imaging period
▸
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Fig. 6  Adverse DILI compound and TNFα synergy for the onset 
of cell death. a Still images of time-lapse movies of HepG2 cells 
exposed to the drugs in the co-presence of Annexin-V-Alexa-633, 
taken at 8 h (before 10 ng/mL TNFα addition) and at 24 h (16 h 
TNFα). b Quantification of the percentage dead cells appearing upon 
drug only exposure, or in combination with TNFα. Average of 3–6 
experiments. c Western blot for cleaved caspase-8 and the caspase 
substrate PARP, induced by 24-h drug alone or drug–TNFα co-treat-
ment. d Comparison of the quantified percentage of dead cells 24 h 
after drug (+TNFα) exposure: the appearance of dead cells in live-
cell imaging as area under the curve (AUC) (as in b) and quantifica-
tion of cleaved caspase-8 protein levels (relative density as in c, aver-
age of three experiments)
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DILI compounds cause a perturbation of NF‑κB 
signaling
To test whether Nrf2 activation by DILI compounds is 
associated with modulation of NF-κB signaling, we made 
use of a previously established HepG2 cell line express-
ing GFP-tagged p65/RelA, a subunit of the dimeric tran-
scription factor NF-κB (Fredriksson et al. 2011). As 
reported (Fredriksson et al. 2011), an 8-h DCF pre-expo-
sure delays the second translocation event (peaking 26 min 
later than vehicle pre-incubated cells) (Fig. 5a). Also 
NTF (+29 min), KTZ (+26 min), AMI (+22 min), NFZ 
(+22 min) and CBZ (+20 min) delayed the oscillation to 
a similar extent as DCF. Pre-treatment with CLZ and MTX 
only weakly perturbed the appearance of the second trans-
location response with a delay of 12 and 9 min, respec-
tively. Neither AMAP, APAP, INH, OFX, SN nor TGZ 
significantly influenced the translocation maximum of the 
second nuclear translocation event.
Our live-cell imaging approach allowed detailed cell 
population-based quantitative analysis of the translocation 
response to extract various relevant parameters that describe 
the NF-κB oscillation pattern invoked by TNFα at the sin-
gle cell as well as the cell population level (Di et al. 2012). 
This analysis revealed that pre-treatment with AMI, CBZ, 
DCF, KTZ, NFZ or NTF significantly delayed the time 
between the first and second NF-κB nuclear translocation 
maxima that normally occur at 30 and 150 min after TNFα 
exposure, respectively (Fig. 5b). This effect limits the aver-
age number of translocation events observed within the 6-h 
imaging window (Fig. 5c). Importantly, by evaluating on 
average ~1000 cells per condition, we identified that AMI, 
CBZ, DCF, KTZ, NFZ and NTF induced a sharp decrease 
in the percentage of cells that undergo three or more NF-κB 
nuclear translocation events (Fig. 5d). Together, the results 
indicate that various DILI compounds affect the TNFα-
induced NF-κB activation response by modulating its 
nuclear translocation dynamics. For the compounds with 
this delayed translocation event, the NF-κB target genes 
are downregulated (Fig. 1a) and all compounds except AMI 
fall within inhibited NF-κB/activated Nrf2 signaling clus-
ters (clusters B–C, and CBZ cluster D, Fig. 1b), suggesting 
that the delayed translocation could be indicative of lower 
NF-κB target gene expression.
The inhibitory effect of Nrf2 activity on NF‑κB 
signaling promotes the pro‑apoptotic role of TNFα 
in drug‑exposed HepG2 cells
TNFα-mediated signaling seems important in DILI (Cos-
grove et al. 2009; Steuerwald et al. 2013). While TNFα-
receptor-mediated NF-κB signaling may provide sur-
vival signaling through the upregulation of anti-apoptosis 
genes such as the anti-apoptotic Bcl-2 family member A1 
(BCL2A1), activation of the TNFR may in parallel initi-
ate activation of caspase-8 and therefore switch on apop-
tosis (Hsu et al. 1996). Since DILI compounds did affect 
the NF-κB signaling and therefore possibly suppressed 
survival signaling, we next investigated whether DILI 
compounds would also predispose to the onset of TNFα-
mediated apoptosis. To address this issue, we monitored 
the rate of HepG2 cell apoptosis by live-cell imaging with 
Annexin-V-Alexa633 after 8-h drug pre-exposure and 
tested whether TNFα co-exposure enhanced the apoptotic 
response at 24 h. TNFα enhanced the apoptosis induction 
upon CBZ and DCF exposure by 18.6 and 9.7 %, respec-
tively. A smaller increase of 3–4 % in cell death upon 
TNFα co-stimulation was found for KTZ, AMI, NFZ and 
CLZ (Fig. 6a, b). Since TNFα-mediated death signaling 
acts through caspase-8 activation, we anticipated that the 
synergy for the onset of apoptosis would also be associated 
with enhanced caspase-8 cleavage. Caspase-8 was mark-
edly increased by TNFα combined with CBZ and DCF, 
yet for other DILI compounds tested, such a caspase-8 
activation was not observed, as was expected based on the 
limited onset of apoptosis (Fig. 6c, d). The enhanced cas-
pase-8 cleavage was associated with cleavage of PARP, a 
well-established caspase substrate which serves as a pivotal 
marker of onset of apoptosis. This indicates that primarily 
under CBZ and DCF pre-treatment conditions, co-treat-
ment with TNFα turns on apoptosis.
Discussion
Here, we focused on the interplay of two pivotal cellu-
lar stress response signaling pathways in DILI: TNFα-
mediated NF-κB signaling and chemical stress-induced 
Nrf2 activation. Extensive transcriptomics data from pri-
mary human hepatocyte revealed that the Nrf2 transcrip-
tional program is activated by a majority of different DILI 
compounds, in particular those that are associated with 
severe DILI. This strong Nrf2 activation correlates with 
a major downregulation of genes that are under the direct 
control of NF-κB. We successfully transferred this inverse 
relationship between Nrf2 activation and NF-κB signaling 
into a panel of GFP-reporter-based high-content imaging 
assays, which now allows the high-throughput assessment 
of their dynamic activation (Wink et al. 2014). Using live-
cell imaging, we established the time profiles of the acti-
vation of these transcription factors and established that 
various DILI compounds activate Nrf2 activity as well 
as negatively modulate the NF-κB nuclear oscillation 
response induced by TNFα. Although no cause and effect 
relationship between these two signaling pathways has 
been proved in our study, our data do support an overall 
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working model whereby DILI compounds that strongly 
affect the Nrf2 response as well as modulate the NF-κB 
oscillatory response (either directly or indirectly) act in 
synergy with TNFα to cause a cytotoxic response. An inte-
grated automated high-throughput microscopy-based plat-
form that simultaneously measures drug-induced Nrf2 acti-
vation, TNFα-induced NF-κB activation and cytotoxicity 
will likely contribute to the exclusion or de-prioritization of 
novel drug entities for further development.
Our data indicate a differential regulation of Nrf2 and 
NF-κB signaling pathways in PHH. From the Japanese 
Toxicogenomics Project, a total of 90 DILI compounds 
have been evaluated. While several DILI compounds 
caused a strong modulation of most Nrf2 and NF-κB tar-
get genes, e.g., NTF, DCF and KTZ, the effect of AMI 
was only modest. Despite the fact that HepG2 cells are 
notorious for their low level expression of CYP enzymes 
(Westerink and Schoonen 2007), an enhanced formation 
of reactive intermediates during drug metabolism may be 
causative for the activation of the Nrf2 response. However, 
we cannot exclude the role of other stress response path-
ways that are intricately linked to the modulation of the 
Nrf2 response and by themselves are activated by chemi-
cal-induced cell injury, including the perturbation of the 
mitochondria, the endoplasmic reticulum (ER) and the 
autophagosomes which may result in a secondary source 
of ROS that may initiate an adaptive Nrf2 response (Sano 
and Reed 2013). Although the role of these other programs 
will require further mechanistic investigations, our previ-
ous investigations demonstrate that suppression of the Nrf2 
adaptive stress response strongly sensitizes cells toward a 
synergistic toxicity with TNFα, indicating that enhanced 
oxidative stress predisposes for TNFα sensitization (Fre-
driksson et al. 2014).
The PHH transcriptomics data indicated that many DILI 
compounds themselves suppress the activity of NF-κB 
target genes. In addition, our imaging data indicate that 
various DILI compounds suppress the NF-κB oscillatory 
response. Together, this suggests that also under control sit-
uations, the overall nuclear localization of NF-κB may be 
limited, thereby precluding the activation of NF-κB target 
genes. Alternatively, a limited activation of NF-κB by DILI 
compounds possibly influences the expression of modu-
lators that act as feedback suppressors of NF-κB activ-
ity, such as IkBα/NFKBIA or A20/TNFAIP3 (Hutti et al. 
2007). Indeed, NF-κB signals through an auto-regulatory 
negative feedback mechanism that essentially desensitizes 
a cell for a limited time period against re-activation of the 
response by an active NF-κB-inducing kinase complex 
(IKK) (Hinz and Scheidereit 2014). Although drug expo-
sure alone may elicit NF-κB oscillations, this does not limit 
the primary nuclear translocation event upon TNFα expo-
sure, only the subsequent nuclear translocation events. The 
later oscillations are less intense and less synchronized 
due to induction of a second negative feedback regulator, 
A20. Interestingly, several, but not all, DILI compounds 
affect the expression of IkBα and A20 in PHH, which often 
occur in parallel, supporting a similar mechanism of acti-
vation (see Supplementary Fig. 7). We therefore turned to 
our GFP-p65 reporter and tested whether the test drugs can 
induce NF-κB oscillations on their own. In line with this, 
we found that DCF, CBZ, NFZ, CLZ and KTZ induced a 
limited NF-κB transition in 2–6 % of a given cell popu-
lation within the first 2 h after exposure which was not 
apparently different from control conditions (Supplemen-
tary Fig. 8). This suggests that drug pre-exposure does not 
directly change the initial balance of NF-κB and its cyto-
plasmic inhibitor, IκBα, but rather may influence the tran-
scriptional and translational responses required for normal 
execution of the timing of the NF-κB response after the 
first nuclear translocation event.
The rationale for the choice of drugs was to investi-
gate whether our live-cell imaging systems were able to 
discriminate between drugs that are often linked to DILI 
(TGZ, AMI, INH, KTZ, NFZ, MTX, NTF, CBZ and DCF) 
and relatively safe drugs (NPX, SN, OFX and CLZ). We 
have focused on NF-κB signaling, Nrf2 activation and cell 
death induction, and a summary of the different responses 
is provided in Table 1. As APAP and AMAP induce hepato-
cellular death through necrosis at high levels of drug con-
centrations (an EC50 in PHH of ~25 mM), and not apopto-
sis, these are considered as relatively safe drugs (Hadi et al. 
2013). Based on our results, NPX, SN and OFX are safe 
(no massive cell death induction, no gross effect on Nrf2 
or NF-κB signaling), but CLZ should be re-evaluated: Its 
profile of strong Srxn1-GFP induction, NF-κB delay and 
slightly higher cell death induced by TNFα co-exposure 
shows more resemblance to drugs that are more often asso-
ciated with DILI, such as DCF, CBZ, KTZ, NFZ and NTF.
Our assays have not been able to pick up any mecha-
nistic signs for toxicity for INH and TGZ, two typical idi-
osyncratic DILI-related drugs (Table 1). The hepatotoxic 
effect of these two drugs, however, could partly depend on 
their inhibitory effect on bile acid transport (Cheng et al. 
2013; Foster et al. 2012), which might only emerge from 
advanced (3D) hepatocyte culture models (Malinen et al. 
2012). Moreover, lack of strong bioactivation capacity 
in HepG2 cells could also be a reason why we could not 
observe any effect for these compounds.
In conclusion, we demonstrate an association between Nrf2 
signaling and NF-κB responses in two distinct liver models: 
PHH and HepG2. Using the live-cell imaging of our GFP-
based reporter models for Nrf2 and NF-κB signaling, we 
established the inverse relationship between these signaling 
pathways in relation to DILI compound and TNFα-mediated 
synergistic toxicity. This was only feasible by assessing the 
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quantitative dynamics of the NF-κB responses, underscoring 
the integration of live-cell imaging of stress response path-
ways in mechanistic studies in relation to DILI assessment.
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